[{"Assets_0_Q3_USD":1547331000.0,"EarningsPerShareBasic_1_Q3_USD":0.79,"EarningsPerShareBasic_3_Q3_USD":2.1,"EarningsPerShareDiluted_1_Q3_USD":0.76,"EarningsPerShareDiluted_3_Q3_USD":2.04,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":155806000.0,"NetIncomeLoss_1_Q3_USD":41672000.0,"NetIncomeLoss_3_Q3_USD":111202000.0,"StockholdersEquity_0_Q3_USD":717523000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":54834000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":54519000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":52873000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":52834000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES INC","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20171102"}]